Cite
MLA Citation
G. Wei et al.. “Entrectinib, a highly potent pan-Trk, ROS1, and ALK inhibitor, has broad-spectrum, histology-agnostic anti-tumor activity in molecularly defined cancers.” European journal of cancer, vol. 69, n.d., pp. S33–. http://access.bl.uk/ark:/81055/vdc_100039473340.0x000028